Find clinical trials for Lung Cancer in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Philadelphia, PA, USA:
in patients undergoing surgical thoracoscopy and resection of lung cancer. Safety is the primary objective of this study, followed ...
Phase 1
Philadelphia, Pennsylvania, United States
Investigators are conducting a pragmatic randomized trial testing the effectiveness of patient and clinician nudge strategies on adherence to lung...
Philadelphia, Pennsylvania, United States
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Camden, New Jersey, United States and 59 other locations
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 30 other locations
in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 48 other locations
This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer...
Phase 3
Horsham, Pennsylvania, United States and 140 other locations
The primary objective of this study is to compare the efficacy of tarlatamab with placebo as assessed by progression free survival (PFS).
Phase 3
Allentown, Pennsylvania, United States and 188 other locations
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T Syst ...
Phase 2
Wynnewood, Pennsylvania, United States and 23 other locations
This is a phase I dose escalation study of CAN-2409 plus prodrug in patients with non-small cell lung cancer (NSCLC). The primary c...
Phase 1
Philadelphia, Pennsylvania, United States
The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\]...
Phase 2
Newark, Delaware, United States and 79 other locations
Clinical trials
Research sites
Resources
Legal